Noninvasive Medical Technologies, Inc.
Noninvasive Medical Technologies helps physicians provide gentler health care. The company manufactures noninvasive hemodynamic monitors that measure blood flow, heart rate, stroke volume, and cardiac output. Its IQ2 is used to assess and evaluate cardiac function. The ZOE device determines if a patient is retaining fluids or is dehydrated without drawing blood. By quickly assessing fluid status, doctors can better treat those at risk for severe or recurring dehydration such as hypertension and heart failure patients and athletes. The company also sells ICG sensors (to obtain hemodynamic data) and electrodes used with its devices. NMT has a supplier agreement with Royal Philips Electronic for its ZOE monitor.
Contact Details
Executives
Chairman and CEO
Ronald McCaughan
COO
Ann McCaughan